Antibody–Drug Conjugates in Cancer Therapy
Innovative drugs designed for oncotherapy are antibody-drug conjugates (ADCs), constructed with monoclonal antibodies, linkers, and natural cytotoxins. Over the past few years, ADCs have had considerable success due to the distinctive benefits of both chemotherapy drugs and antibody drugs. The
Read More